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Abstract
Monocytes/macrophages are key players in all phases of physiological and pathological inflammation. To understanding the
regulation of macrophage functional differentiation during inflammation, we designed an in vitro model that recapitulates
the different phases of the reaction (recruitment, initiation, development, and resolution), based on human primary blood
monocytes exposed to sequential changes in microenvironmental conditions. All reaction phases were profiled by
transcriptomic microarray analysis. Distinct clusters of genes were identified that are differentially regulated through the
different phases of inflammation. The gene sets defined by GSEA analysis revealed that the inflammatory phase was
enriched in inflammatory pathways, while the resolution phase comprised pathways related to metabolism and gene
rearrangement. By comparing gene clusters differentially expressed in monocytes vs. M1 and vs. M2 macrophages extracted
from an in-house created meta-database, it was shown that cells in the model resemble M1 during the inflammatory phase
and M2 during resolution. The validation of inflammatory and transcriptional factors by qPCR and ELISA confirmed the
transcriptomic profiles in the different phases of inflammation. The accurate description of the development of the human
inflammatory reaction provided by this in vitro kinetic model can help in identifying regulatory mechanisms in physiological
conditions and during pathological derangements.
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Introduction
In the healthy organism the innate immune system provides the
first line of defence against external or internal danger signals, and
functions by triggering a protective inflammatory reaction
develops through different phases, from initiation to full inflam-
mation and destruction of the initiating agent, followed by
resolution, and re-establishment of tissue integrity with restoration
of the physiological tissue functions. Briefly, when in a tissue a
damage or an infection takes place, the innate immune system is
activated, setting in motion a local inflammatory response that
includes the recruitment of leukocytes from blood (first neutrophils
and them monocytes) and the production of a series of pro-
inflammatory mediators, such as TNF-a and IL-1b, by local
immune cells (in particular the resident macrophages). NK and T
cells can also enter the tissue in response to specific chemokines,
and may influence the development of the inflammatory reaction
by producing IFN-c, a potent monocyte/macrophage inflamma-
tory activator. An inflammatory reaction must be tightly controlled
to avoid excessive collateral damages to host tissues, and the
possible degeneration into pathological conditions (e.g., chronic
inflammatory or autoimmune diseases). Thus, a crucial commit-
ment made in late inflammation is to convert the response from
the cytocidal tissue-damaging mode to a tissue-repairing mode.
Clearance of the initiating stimulus (e.g., elimination of the
infectious microorganisms) determines the cessation of the
inflammatory stimulation and the concomitant activation of
down-regulatory mechanisms (in which cytokines such as IL-10
are involved), leading to resolution of inflammation. Then, in the
different microenvironment, innate immune cells produce a series
of growth factors (including VEGF and TGF-b) thereby taking
part in the final phase of tissue re-construction and re-establish-
ment of homeostasis [1].
Monocytes/macrophages are key players in inflammatory host
defense, both by the direct elimination of foreign agents and as
organisers of the different phases of the inflammatory process [2].
Circulating monocytes enter tissues and become inflammatory
macrophages upon tissue damage. Resident tissue macrophages
have a role in tissue surveillance and homeostasis [3]. Both
incoming inflammatory monocytes and resident macrophages can
undergo different activation processes as a consequence of
microenvironmental tissue-derived (damage) or cell-derived signals
(microbes, activated lymphocytes) [4–6]. Two broad macrophage
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functional phenotypes have been proposed, mirroring the Th1/
Th2 polarization. The classically activated macrophages (M1)
develop in response to inflammatory factors like the Th1 cytokine
IFN-c, LPS and TNF-a, and mediate resistance against intracel-
lular parasites and tumours [7,8]. Alternative M2 macrophages
are activated by Th2 cytokines, or FccR binding in the presence of
TLR agonists, or glucocorticoids and anti-inflammatory molecules
(M2a, M2b, M2c respectively), and take part in parasite clearance,
dampening of inflammation, tissue remodelling, and tumour
promotion [9,10].
Several in vitro and in vivo studies suggest that polarised M1 and
M2 macrophages can to some extent switch from a phenotype to
the other. A controversial issue is whether M1 and M2
macrophages consist of phenotypically distinct subpopulations
that can serve different functions [11,12], or the same cells can
shift from one to another functional phenotype based on
microenvironmental signals [13]. While in several pathological
conditions the latter seems to be the case (e.g. obesity-induced
insulin resistance [14], atherosclerotic lesions [15], cancer [16],
endotoxin tolerance [17]), it is still unknown if M1 and M2
macrophages can undergo dynamic transitions between different
functional states during a ‘‘physiological’’ inflammatory response.
Gene expression profiling approaches have been used to cast light
on monocyte-to-macrophage differentiation and polarization
processes, on the recognition of molecular signatures in M1 and
M2 macrophages, and on the understanding of the plasticity of
macrophage activation [18,19]. In the last sixty years, many
studies on macrophage activation in inflammation relied on in vivo
mouse models [20], and on in vitro models based on isolated
murine primary cells (mainly peritoneal or bone marrow derived
macrophages) and on immortalised monocytic cell lines (human or
murine) [21]. More recently, data on human primary cells have
also become available, obtained with human monocytes/macro-
phages ex vivo or in vitro (primary macrophages isolated from tissues,
in vitro differentiated myeloid precursors, in vitro matured macro-
phages, peripheral blood monocytes) [18]. These studies investi-
gated the activation of monocytes/macrophages, and provided
information about the modes of type I vs. type II inflammatory
activation vs. deactivation of macrophages in the human being.
However, no information is available on the kinetic development
of the macrophage inflammatory reaction and on the possibility
that the same cell population could be first polarised towards an
effector inflammatory program and subsequently re-polarized to
the deactivation program. In this context, this study aims at
providing such characterisation by setting up a reliable and
representative model, based on human primary monocytes, that
allows us to accurately describing the development and regulation
of human macrophage functions during the entire course of the
inflammatory reaction.
Materials and Methods
Monocyte isolation and culture
Human monocytes were obtained from discarded buffy coats of
healthy blood donors (see the paragraph ‘‘Ethics statement’’).
Donors were aged 19–56 years (average 35.5 years), included
females and males (10+2) and belonged to three different ethnic
groups, in the attempt to capture at least partially the human
heterogeneity. According to the Italian law, blood donors were
clinically healthy, were screened and found negative for HIV,
HBV and HCV, and were within the normal range for CBC
(complete blood count), glycemia, cholesterol, triglycerides,
transaminases, creatinine, and blood protein level. Monocytes
were obtained by isolating PBMC on Ficoll-Paque PLUS gradients
(GE Healthcare, Bio-Sciences AB, Uppsala, Sweden) and subse-
quent separation with Monocyte Isolation kit II (Miltenyi Biotec,
Bergisch-Gladbach, Germany). Monocytes isolated by this tech-
nique encompassed about 80% CD14++CD162 cells, 2–6%
CD14++CD16+ cells, and 7–10% CD14dimCD16+ cells, thus fully
reflecting the distribution of blood monocyte subpopulations [22].
Only preparations with .98% purity (determined by differential
staining on cytocentrifuge smears) and viability (trypan blue dye
exclusion) were used.
Monocytes were cultured at 56106 cells/well in 6-well culture
plates (CostarH, Corning Inc., Corning, NY) in 2 ml of RPMI
1640+Glutamax-I Medium (GIBCOH, Life Technologies, Paisley,
UK) supplemented with 50 mg/ml Gentamicin (GIBCOH) and 5%
heat-inactivated human AB serum (Sigma-Aldrich Inc., St. Louis,
MO) in moist air with 5% CO2. Monocytes were sequentially
exposed to mixtures of stimuli (see Results): hrCCL2 (10 ng/ml),
hrTNF-a (10 ng/ml), hrIFN-c (25 ng/ml), hrIL-10 (20 ng/ml),
hrTGF-b (10 ng/ml) (all from R&D Systems, Minneapolis, MN),
LPS (5 ng/ml; from E.coli serotype 055:B5; Sigma-Aldrich). Cells
were washed and fresh medium added at 2, 14 and 24 h. Viability
at 48 h always exceeded 80%.
Fresh monocytes were taken as time 0. Cells were harvested in
700 ml of Qiazol (Qiagen, Hilden, Germany) at 2, 2.5, 3, 3.5, 4,
14, 24, and 48 h. Supernatants were collected at 4, 14, 24, and
48 h.
RNA isolation and microarray hybridization
Total RNA was extracted from monocytes of 12 individual
donors (3 for the ‘‘early’’ series: 0, 2.0–3.5 h; and 9 for the ‘‘late’’
series: 0, 4–48 h), using Qiagen miRNeasy kit (Qiagen), quantified
spectrophotometrically (ND-1000, NanoDrop Technologies, Wil-
mington, DE), and checked for integrity by microcapillary
electrophoresis (Agilent 2100 Bioanalyzer; Agilent Technologies,
Palo Alto, CA). Samples were prepared starting from 0.1–1 mg
total RNA, using the GeneChipH 39 IVT Express kit or the
GeneChipH One Cycle cDNA Synthesis kit (Affymetrix, Santa
Clara, CA), with identical results. Biotinylated cRNAs (15 mg)
were fragmented and hybridized for 16 h at 45uC onto
GeneChipH HG-U133 Plus 2.0 Arrays (Affymetrix). After washing
and staining, arrays were scanned with the GeneChipH Scanner
3000 7G (Affymetrix) and fluorescent images were acquired and
analyzed using GCOS software (Affymetrix) to generate a total of
60 raw intensity files (CEL files).
Data analysis
Analysis was performed in R using Bioconductor libraries and R
statistical packages. Signals were converted to expression values by
robust multi-array average procedure [23] and HG-U133 Plus 2.0
custom Chip Definition Files (CDF) based on GeneAnnot [24]
(CDF Version 2.1.0, GeneCards Version 2.41, GeneAnnot
Version 1.9). Intensity levels for a total of 18862 custom probe
sets were background-adjusted and normalised using quantile
normalisation, and log2 expression values calculated using median
polish summarisation. Raw data are available at Gene Expression
Omnibus (GEO) GSE47122.
Genes with statistically significant differential expression during
time series were identified using the microarray Significant Profiles
method coded in the R package maSigPro [25]. MaSigPro first
applies a least-square technique to estimate the parameters of a
general regression model for each gene (make.design function) and
then uses the regression coefficients of the model to identify genes
with statistically significant changes in their expression profiles
(p.vector, T.fit and get.siggenes functions). Since the time-course
was composed of 9 points, we computed a regression fit for each
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gene using a polynomial with a degree of 3 (cubic regression
model) and selected those regression models with an associated
corrected p value#0.05. P values have been corrected for multiple
comparisons using the false discovery rate procedure (FDR), i.e.,
setting the parameter Q=0.05 in the p.vector function. Once the
statistically significant gene models were determined, the regres-
sion coefficients were used to identify genes showing statistically
significant expression changes over time. To do this, a second
model was constructed using only significant genes and applying a
variable selection strategy based on stepwise regression. Specifi-
cally, we selected the backward stepwise regression and, at each
iteration, retained those variables with a p value#0.01 (i.e., set the
T.fit parameters at step method= backward and alpha= 0.01).
Finally, we generated the list of significant genes by setting an
additional selection criterion based on the R-squared value of the
second regression model (i.e., set the get.siggenes parameters
rsq = 0.6 and vars = all). Results have been visualised clustering
genes into k = 9 groups, using maSigPro k-mean clustering and
default value for k.
Analysis of publicly available gene expression data
Gene expression data of human primary monocytes and
macrophages were retrieved from GEO repository (http://www.
ncbi.nlm.nih.gov/geo), using as inclusion/exclusion criterion the
type of microarray technology (i.e., only data obtained with
Affymetrix HG-U133 microarrays were considered). Twenty-four
series comprising 474 samples were downloaded from GEO, and
303 samples (corresponding to monocytes and macrophages, and
excluding dendritic cells) were selected and organised in a
proprietary database using the software A-MADMAN [26] (Table
S1). Samples were manually re-annotated and tagged based on the
meta-information provided by GEO and by the original
publications. Finally, the meta-database comprised 62 samples
labelled as untreated monocytes, and 46 and 20 samples as M1
and M2 activated monocytes/macrophages, respectively (Table
S2). Gene expression profiles were generated starting from CEL
files using an approach inspired by the generation of custom CDF
[27]. In custom CDF, probes matching the same transcript, but
belonging to different probes sets, are aggregated into putative
custom-probe sets, each one including only those probes with a
unique and exclusive correspondence with a single transcript.
Similarly, probes matching the same transcript but located at
different coordinates on different type of arrays may be merged in
custom-probe sets and arranged in a virtual platform grid. As for
any other microarray geometry, this virtual grid may be used as a
reference to create the virtual-CDF file, containing the probes,
shared among the platforms of interest, and their coordinates on
the virtual platform, and the virtual-CEL files containing the
intensity data of the original CEL files properly re-mapped on the
virtual grid. Once defined the virtual platform through the
creation of its custom-CDF and transformed the CEL files into
virtual-CEL files, raw data, originally obtained from different
platforms, are homogeneous in terms of platform and can be pre-
processed and normalised adopting standard approaches, as RMA
or GCRMA. Here, expression values were generated from
intensity signals using the combined HG-U133A/HG-
U133Av2/HG-U133 Plus2.0 virtual-CDF file, the custom defini-
tion files for human GeneChips based on GeneAnnot, and the
transformed virtual-CEL files. Intensity values for a total of 12167
meta-probesets were background-adjusted, normalised using
quantile normalisation, and gene expression levels calculated
using median polish summarisation (RMA algorithm) [23]. The
expression matrix has been analysed with the Significance Analysis
of Microarray method (SAM) [28], coded in the samrRpackage
(http://cran.r-project.org/web/packages/samr/index.html), to
identify differentially expressed genes in the comparisons between
subsets of monocytes tagged as untreated, M1, and M2 (128
samples, see Table S2). Specifically, in the comparison between
untreated monocytes and samples labelled as M1 (or as M2), we
used the two-class procedure, estimated the percentage of false
positive predictions with 1000 permutations, and selected those
transcripts whose q-value (i.e., False Discovery Rate, FDR) was
equal to 0. This selection was further refined setting the lower limit
for fold change induction (or reduction) to 5 and 8, when
considering the comparison between untreated monocytes and
samples M1 or untreated monocytes and samples M2, respective-
ly.
Over-representation analysis
Over-representation analysis was performed using the Gene Set
Enrichment Analysis (GSEA) software [29] and gene sets from the
Molecular Signatures Database (http://www.broadinstitute.org/
Figure 1. Graphic representation of the kinetic development of inflammation in the human monocyte-based in vitro model. Freshly
isolated human blood monocytes were first exposed to the chemokine CCL2 for 2 h at 37uC, then to LPS (from 2 h), TNF-a (from 3 h), and IFN-c (from
7 h) at 39uC. At 14 h the inflammatory stimuli were washed off, the temperature brought back to 37uC, and fresh medium containing IL-10 added. At
24 h monocytes were exposed to TGF-b until the end of the experiment.
doi:10.1371/journal.pone.0087680.g001
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gsea/msigdb/index.jsp). GSEA was applied on log2 expression
data of the entire time course. The median expression profiles of
the 9 groups of genes identified by maSigPro was used as
continuous phenotype labels, and the Pearson’s correlation as the
metric to select gene sets with expression patterns resembling those
encoded in the phenotype labels. As gene sets we used KEGG,
Biocarta, and Reactome lists of the C2: curated gene sets
collection. Finally, gene sets were defined as significantly enriched
if the False Discovery Rate (FDR) was ,5% when using Pearson
as metric and 1,000 permutations of gene sets.
Gene expression validation by qRT-PCR
cDNAs were reverse-transcribed from total RNA (100 ng) using
High Capacity cDNA Archive Kit (Applied Biosystems, Foster
City, CA). TaqMan qPCR assays were performed with an ABI
PRISM 7900 sequence detection system (Applied Biosystems),
using TaqMan Universal PCR Master Mix (Applied Biosystems)
in 50 ml reaction volume. Primers and probes for IL6, TNFA,
IL7R, CD163, MMP9, MAFB, KLF4, PPARG, PPARD, CEBPA, and
GAPDH were supplied by Applied Biosystems as pre-made
solutions. Each cDNA sample was run in triplicate and qRT-
PCR reactions were carried out on six independent samples.
Statistical analysis was performed using the (22DDCt) method [30].
Results are expressed as mean 6 standard error (SEM) of relative
quantity (RQ) of mRNA level variations vs. calibrator (fresh
monocytes).
Protein detection by ELISA
Production of IL-6 and chemokines, CXCL8 (IL-8) and CCL5
(RANTES), was measured on cell supernatants by ELISA (R&D
Systems Minneapolis, MN), according to manufacturer’s instruc-
tions. Each sample was assayed in duplicate.
Statistical analysis
The qRT-PCR and ELISA results are expressed as mean values
6 SEM. Differences between groups were analyzed using
ANOVA and Fisher’s test. A P value,.05 was considered
statistically significant.
Ethics statement
No ethical approval or informed consent is required by the
Italian law for discarded blood products. In any case, the use of the
blood samples from normal donors for the study of monocyte
activation and polarization was included in a collaborative study
with Prof. Paola Migliorini on monocyte activation in normal and
autoimmune subjects, which was approved by the Ethical
Committee of the University of Pisa S. Chiara Hospital (prot.
AOUP 33998 of September 29, 2006), and which is still ongoing.
All samples of human blood included in this study were from
anonymous donors and all were donated by Prof. Migliorini.
Results
The in vitro monocyte-based model of inflammation
Blood monocytes from 12 individual healthy donors were
exposed to a sequence of culture conditions mimicking the
evolving microenvironment during an inflammatory reaction
(Figure 1). Monocytes were initially exposed to CCL2 at 37uC,
to represent recruitment to the site of inflammation, then to LPS
and, sequentially, to TNF-a and IFN-c at 39uC, to mimic the
encounter with infectious agents and the inflammatory microen-
vironment (tissue reaction and influx of Th1 cells). At 14 h, culture
conditions were changed (37uC and medium containing IL-10 first
and subsequently TGF-b) to reproduce activation of anti-
inflammatory mechanisms and macrophage deactivation during
resolution.
Distinct gene signatures are identified during the
inflammatory response
Transcriptomic analysis was performed on monocytes from
each individual donor at five different stages of activation in
comparison to control fresh monocytes (time 0): early inflamma-
tion (2–4 h), late inflammation (14 h) (both corresponding to M1
polarization); early and late resolution (24 and 48 h) (different
stages of M2c polarization).
Genes showing statistically significant expression changes over
time were identified by using the microarray Significant Profiles
Figure 2. Differential gene expression during the inflammation
phases. Heat-map showing the fold-expression levels of the genes that
were identified by maSigPro as coherently downregulated (green) or
upregulated (red) within the experimental set of 60 samples. Genes are
organised into five major functional groups characterising the different
phases of inflammation in this experimental setting: Inflammation (392),
Early Anti-Inflammation and Anti-Inflammation (1871), Inflammation
Driven Differentiation (457), Positive Differentiation (214) and Negative
Differentiation (1061).
doi:10.1371/journal.pone.0087680.g002
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method (maSigPro R package) with parameters specified in (Figure
S2). Results revealed profound changes in gene expression during
the different phases of the inflammatory reaction, and the
concomitant monocyte-to-macrophage differentiation. A total of
3995 genes (21.18% of the 18862 genes examined) resulted
differentially expressed during the course of inflammation at a
95% confidence level (false discovery rate (FDR)#0.05). Using k-
means clustering method and maSigPro default parameters,
significant genes were grouped in nine clusters showing distinct
expression profiles during the inflammatory reaction (Figure S1).
The nine clusters were merged into five major functional groups
characterising the different phases of inflammation (Figure 2). The
Inflammation functional group, encompassing clusters 1 and 2, is
associated with the modulation of 392 transcripts. Of these, 218
are transiently upregulated during the first four hours of the
inflammatory process, while 174 remain highly expressed during
Table 1. Most representative gene sets associated with the Inflammation, Early Anti-Inflammation and Anti-Inflammation
functional groups.
Functional groups FDR q-val
Inflammation
BIOCARTA_NFKB_PATHWAY 0.003
BIOCARTA_IL-1R 0.010
BIOCARTA_IL-10_PATHWAY 0.013
BIOCARTA_INFLAM_PATHWAY 0.021
BIOCARTA_CD40_PATHWAY 0.033
BIOCARTA_CYTOKINE_PATHWAY 0.044
KEGG_MAPK_SIGNLING 0.000
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_SIGNALING 0.000
KEGG_NOD_LIKE_RECEPTOR_SIGNALING 0.000
KEGG_ECM_RECEPTOR_INTERACTION 0.001
KEGG_CELL_ADHESION_MOLECULES_CAMS 0.005
KEGG_PATHWAY_IN_CANCER 0.008
KEGG_JAK_STAT_SIGNALING 0.011
KEGG_NOTCH_SIGNALING 0.015
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING 0.037
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES 0.000
REACTOME_GPCR_LIGAND_BINDING 0.000
Early Anti- and Anti-Inflammation
KEGG_OXIDATIVE_PHOSPHORYLATION 0.000
KEGG_RNA_DEGRADATION 0.001
KEGG_FATTY_ACID_METABOLISM 0.014
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM 0.000
REACTOME_ELECTRON_TRANSPORT_CHAIN 0.000
REACTOME_INTEGRATION OF ENERGY METABOLISM 0.000
REACTOME_METABOLISM_OF_CARBOHYDRATES 0.000
REACTOME_PYRUVATE_METABOLISM_AND_TCA_CYCLE 0.000
REACTOME_METABOLISM_OF_PROTEIN 0.000
REACTOME_DIABETES_PATHWAYS 0.000
REACTOME_METABOLISM_OF_RNA 0.003
REACTOME_FORMATION_AND_MATURATION_OF_MRNA_TRANSCRIPTS 0.004
REACTOME_MRNA_SPLICING 0.009
REACTOME_METABOLISM_OF_MRNA 0.011
REACTOME_GENE_EXPRESSION 0.016
REACTOME_MICRORNA_BIOGENESIS 0.040
REACTOME_CELL_CYCLE_MITOTIC 0.000
REACTOME_G1_S_TRANSITION 0.000
REACTOME_G2_M_CHECKPOINTS 0.031
KEGG, Biocarta, and Reactome gene sets have been obtained from the C2: curated gene sets collection of the Molecular Signatures Database. Gene sets were defined as
significantly enriched if FDR,0.05 when using Pearson as metric and 1,000 permutations of gene sets. The complete list of the Gene sets identified by GSEA is available
with the authors.
doi:10.1371/journal.pone.0087680.t001
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the late inflammation phase, and all decrease during the resolution
phase. The Early Anti-Inflammation/Anti-Inflammation group, corre-
sponding to clusters 3–5, contains 1871 genes, and includes genes
that are downregulated in M1 polarised cells. Their median
expression levels rapidly decrease upon stimulation with LPS/
TNF-a, to eventually return to basal level in the resolution phase.
Expression of the 457 genes in the Inflammation Driven Differentiation
group (corresponding to cluster 6) rapidly increases upon
inflammatory stimulation and remains elevated through the
subsequent phases of the reaction. The Positive Differentiation group
(cluster 7) includes 214 genes downregulated in fresh monocytes
and during the early inflammation phases, but progressively
upregulated during time with a transcriptional peak during late
resolution. Conversely, the Negative Differentiation group (clusters 8
and 9) comprises a total of 1061 genes highly expressed in fresh
monocytes and in early inflammation, and reduced during the
subsequent phases. The list of all the 3995 differentially expressed
genes, grouped in the nine clusters, is reported in the Table S3.
Pathway analysis reveals relationship between activation
and differentiation
Gene groups were subjected to GSEA for statistical associations
between expression profiles of distinct groups and other gene
signatures characteristic of various pathways or cellular processes
described in KEGG, Biocarta and Reactome databases. We
identified a total of 155, 358, 55, 149, and 66 pathways strongly
associated with the expression profile of the five functional groups.
The most representative gene sets associated with Inflammation,
Early Anti-Inflammation and Anti-Inflammation are listed in Table 1.
Figure 3. Differentially expressed genes in M1 and M2 macrophages vs. monocytes. Heat-maps representing the fold-expression levels of
gene lists identified by SAM as statistically downregulated (green) or upregulated (red) in M1 and M2 samples compared to fresh unstimulated
monocytes. The lists excluded genes that are modulated in both M1 and M2 vs. monocytes. (A) Fold-expression levels in monocytes and M1
macrophages of the meta-database for the 98 genes associated to monocyte-to-M1 differentiation. (B) Fold-expression levels in monocytes and M2
macrophages of the meta-database for the 107 genes associated to monocyte-to-M2 differentiation. (C) Fold-expression levels of the 98 monocyte-
to-M1 genes assessed in the 60 samples of our in vitro model of inflammation. (D) Fold-expression levels of the 107 monocyte-to-M2 genes assessed
in the 60 samples of our in vitro model of inflammation.
doi:10.1371/journal.pone.0087680.g003
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The majority of gene sets associated to Inflammation are pathways
involved in classical inflammatory activation, and were not found
associated to other groups (except Inflammation Driven Differentiation).
The Early Anti-Inflammation and Anti-Inflammation clusters are
enriched in pathways associated to metabolism and regulation of
gene expression. The Inflammation Driven Differentiation group is
associated to signalling cascades common to both inflammatory
and anti-inflammatory phases, while pathways enriched in the
Positive Differentiation and Negative Differentiation groups are similar to
those found in the anti-inflammatory phase.
The M1 inflammatory signature develops into M2 during
resolution
To assess the transition from M1 to M2 polarization, we merged
24 publicly available human microarray studies into a meta-
dataset using A-MADMAN, and extracted gene expression data
for 62 fresh monocyte samples, 46 M1 (treated with LPS/TNF-a
or IFN-c) and 20 M2 samples (M2c; treated with glucocorticoids,
IL-10 or TGF-b). Gene expression signals of the meta-dataset
were generated using the Virtual-chip approach that integrates raw
expression data obtained from different Affymetrix arrays. The
meta-dataset was analyzed with the SAM algorithm, to identify a
list of genes differentially expressed in unstimulated monocytes,
M1 and M2 macrophages.
The statistical comparison returned that monocyte-to-M1
differentiation is associated with modulation of 98 genes, of which
85% are highly expressed in M1 and 15% in monocytes
(Figure 3A, Table S4), while monocyte-to-M2 differentiation
resulted in the modulation of 107 genes, 62% highly expressed in
M2 and 38% in monocytes (Figure 3B, Table S5). Transcripts that
are upregulated in M1 cells vs. monocytes included cytokines and
chemokines, while those upregulated in M2 cells included enzymes
and extracellular mediators. The two signatures of M1 and M2
polarization were used to cluster samples of our in vitro model of
inflammation. As shown in the Figure 3C, fresh monocytes showed
a gene expression profile fully overlapping with that of
unstimulated monocytes in the meta-database, then they presented
a M1-like expression profile during the inflammatory phases, to
return to a monocyte-like profile in the resolution phase. When
considering the gene set that discriminates monocytes from M2
cells, fresh monocytes showed the same profile as the untreated
monocytes of the meta-database, and this profile gradually
changed during the progression of inflammation, to become
similar to that of M2 macrophages at the end of resolution phase
(Figure 3D).
When comparing the list of genes differentially expressed during
the inflammation process (Figure 2) with the list of genes
differentially expressed in monocytes vs. M1 (Figure 3A), a large
number of genes expressed in M1 cells (34%) belong to the
Inflammation group. Conversely, 21% of genes expressed in M2
cells belong to the Positive Differentiation group and are expressed
only during the resolution phase. In the monocytes vs. M1
comparison, a large part of genes expressed in fresh monocytes
belongs to the Anti-Inflammation group (26%), while in the
monocytes vs. M2 comparison 51% of genes expressed in
monocytes are in the Negative Differentiation group. Among genes
common to both M1 and M2 polarization, several belong to the
Inflammation Driven Differentiation group (14% and 20%, respective-
ly). Table 2 shows some representative genes identified in these
comparisons.
qRT-PCR and ELISA validation
A subset of ten genes was assessed by qRT-PCR, employing the
same RNA samples used to perform microarray experiments, five
transcription factors chosen as markers of monocyte differentia-
tion, and five inflammation-related factors as markers of monocyte
activation, selected within each functional group of Figure 2. The
qPCR results confirmed the expression patterns observed by
microarray analysis (Figure 4). Genes belonging to the Inflammation
group (PPARG, IL6, TNFA) were upregulated during the early
phase, while IL7R was over-expressed during the late phase of
inflammation. CD163 (Early Anti-Inflammation) was highly upregu-
lated at the beginning of resolution, possibly induced by IL-10,
while the transcription factor CEBPA (Anti-Inflammation) was
overexpressed during late resolution, possibly induced by TGF-
b. Expression of PPARD (Inflammation Driven Differentiation) increased
during late inflammation and remained elevated, while MAFB and
MMP9 genes (Positive Differentiation) were upregulated during
resolution. Finally, expression of KLF4 (Negative Differentiation) was
high in fresh monocytes and decreased thereafter.
Production and secretion of the inflammatory cytokine IL-6 and
of the M1 polarization-associated chemokines CXCL8 (IL-8) and
CCL5 (RANTES) were evaluated in terms of rate of production
and resulted abundantly produced during the inflammatory phase,
to be turned off during resolution (Figure 5). Production of CCL5
was already significant after stimulation with CCL2 only, in
Table 2. Correlation between M1/M2 polarization and functional groups.
Gene Symbol Functional Groups
Genes upregulated in M1 polarization
IL12B, PTX3, CCL4, IL1RN, TNF, IL6, CCL20, IL1A, ICAM1, NFKB1, TRAF1, SERPINB9, IL1F9, MAFF Inflammation
CXCL1, DRAM, TNIP3, CCL2, SLAMF7, CCR7, TNFAIP6 Inflammation Driven Differentiation
Genes downregulated in M1 polarization
P2RY5, FGL2, CD1D Anti-Inflammation
Genes upregulated in M2 polarization
TREM2, A2M, NUPR1, C1QA, MS4A4A, APOE, APOC1, ADORA3 Positive Differentiation
ADAMDEC1, CD59, TFPI, CCL3 Inflammation Driven Differentiation
Genes downregulated in M2 polarization
FCER1A, LGALS2, PF4, CD69, CD93, NR4A2, VCAN, CD62L, ICAM3, NLRP3, ERG1 Negative Differentiation
Association of gees that are up- or downregulated in M1 and M2 cells polarisation (Figure 3A and B) with the functional groups defined from the analysis of the in vitro
model of inflammation (Figure 2).
doi:10.1371/journal.pone.0087680.t002
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Figure 4. Gene expression validation by qPCR. Fold-expression levels determined by qPCR for the 10 genes selected in the Inflammation
(PPARG, IL6, TNFA, IL7R), Early Anti-Inflammation (CD163), Anti-Inflammation (CEBPA), Inflammation Driven Differentiation (PPARD), Positive
Differentiation (MMP9 and MAFB), and Negative Differentiation (KLF4) groups. The mean expression values 6 SEM from six different donors are
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agreement with previous findings that CCL2 can induce
chemokine production in monocytes [31].
Discussion
In this study, we set up an in vitro model of inflammation based
on human primary monocytes with the aim of describing the
kinetics of the inflammatory reaction, from initiation and
development until eventual resolution. The use of normal human
cells allowed us to study the mechanisms of inflammation in a
system that readily translates to human responsiveness in vivo, as
opposed to mouse models [32,33] or transformed cell systems
[34,35]. Transcriptomic profiling was performed on monocytes
from 12 healthy donors, selected over a large age range (19–56
years), including both females and males, and encompassing
individuals of three different ethnic groups. This heterogeneity is
expected to capture, at least partially, the human variability.
Despite such heterogeneity, the gene expression profiles of the
donors appeared to be very reproducible, both in fresh monocytes
and in response to all the stimulation conditions at the different
time points, suggesting that the monocyte response is highly
reliable and robust. It should be said that additional experiments
(where expression of a limited number of gene was performed by
real-time PCR) have brought the number of donors to over 60,
and we never observed significant discrepancies in the monocyte
type and kinetics of response (Italiani et al., unpublished). Also, the
use of viral stimuli instead of LPS, besides triggering a virus-
specific signature, did essentially bring about a response that
largely overlapped that described in this study (Boraschi et al.,
unpublished).
The in vitro model of inflammation presented here aims at
representing, in a simplified fashion, the course of an inflammatory
reaction in a tissue, limited to the role of newly recruited
inflammatory blood monocytes. In fact, the simplified model does
not include resident tissue macrophages, highly differentiated cells
with a clear M2 bias, that are the cells initiating inflammation and
responsible for the recruitment of blood monocytes, nor other cell
types. Also, the role of extracellular matrix components and of the
tissue architecture is not considered in this model. Although there
is some evidence that EMC do not affect macrophages polariza-
tion [36], it is likely that the structure of the tissue environment has
a role in determining the response outcome. More complex
models, to reproduce the inflammatory response of both
infiltrating monocytes and resident macrophages in specific tissues,
are underway in our lab. Taking in consideration the limitations of
the present model, its advantages are its simplicity and robustness
(with responses that are the same in different donors and in
different stimulation conditions), its accurate kinetic description of
monocyte inflammatory reaction and the passage from monocytes
to M1 and then to M2, and its higher validity in describing human
inflammation, as opposed to the use of transformed cell lines or
animal cells.
Many genes were differentially expressed throughout the
inflammatory reaction and the concomitant monocyte-to-macro-
phage differentiation. Homogeneity of gene expression profiles
among different donors underlines the robustness of the model.
Supervised hierarchical clustering allowed defining five major
functional groups of modulated genes. The Inflammation cluster,
corresponding to monocyte-to-M1 differentiation, includes genes
encoding classical inflammatory effectors, such as inflammatory
cytokines (IL1B, IL6, TNFA, IL12B), chemokines (CXCL8, CCL5,
CCL20), soluble innate mediators (PTX3, EDN1, APOL2), and
enzymes (PTGS2, PLA1A). Early Anti-Inflammation and Anti-Inflam-
mation include genes downregulated in M1 polarised cells, i.e.,
genes encoding transcriptional factor such as CCAAT/enhancer
binding protein alpha (CEBPA), innate receptors (TLR5, TLR7,
TLR8), purinergic receptors (P2RX7), FcR (FCER1A, FCRLB), and
metallothionein genes (MT1G, MT4, MT1E, MT1M, MT1F,
MT1X), involved in modulation of inflammation, control of the
oxidative stress, cell proliferation [37], and strongly upregulated in
endotoxin tolerance [38]. The decreased expression of inflamma-
tory receptor genes may be related to loss of responsiveness
following activation (similar to tolerance), which is restored at the
end of inflammatory process when inflammatory monocytes have
become tissue-regulating macrophages ready to respond to a new
danger signal.
Inflammation Driven Differentiation encompasses genes whose
expression rapidly increased at the onset of inflammation and
remained upregulated throughout. These genes may be needed
both for the inflammatory response and for monocyte differenti-
ation into tissue-repairing macrophages. Indeed, this cluster
includes inflammatory genes and M1 polarization markers
(IL7R, CCR7, CCL19, CXCL11), and several genes highly expressed
in M2c polarization (IL10, CCL24, CCL22). Positive and Negative
Differentiation include genes important for monocyte-to-macro-
phage differentiation, such as transcription factors (MAFB, KLF4,
PPARG), c-type lectins (CLEC3B, CLEC7A, CLEC10A, CLEC11A),
adhesion (SELL, ICAM3, AMICA1) and signalling molecules (MAP
kinases), and extracellular mediators (C1Q, APOE). These genes
may define the differentiation of monocytes to macrophages
independently of the concurring inflammatory reaction. Indeed,
monocytes used in these experiments are a heterogeneous
population as present in the blood and could therefore include
both ‘‘inflammatory’’ monocytes differentiating into effector cells
in the tissue, and ‘‘homeostatic’’ monocytes replenishing the pool
of tissue macrophages in physiological conditions [6,39].
The majority of pathways identified in the Inflammation cluster
are involved in innate immune activation and type I inflammation
(NFkB, MAPK and JAK-STAT signalling, NLR and TLR
signalling, cytokine/chemokine receptor interaction, IL-1R path-
way), while the Early Anti-Inflammation and Anti-Inflammation clusters
are enriched in pathways associated to lipid, protein, and
carbohydrate metabolism, regulation of gene expression (RNA
splicing and miRNA biogenesis), and cell cycle. The same
pathways were found in the Positive Differentiation cluster. The
modulation of genes involved in cellular metabolic activities is a
prominent feature of M2 macrophage polarization/differentiation
[40–42], and during the resolution and repair phases, when major
rearrangements of cellular functions are required for shifting from
inflammation to anti-inflammation and tissue repair. The enrich-
ment in pathways associated with cell cycle agrees with previous
observations [43], and underlines the importance of proliferation
in M2-polarised macrophages [44], although its in vivo relevance is
still debated. By comparing the genes differentially expressed
between monocytes vs.M1 and vs.M2, it is evident that monocytes
in our model show an M1 signature in the inflammatory phase and
an M2 profile during resolution. Most genes expressed in M1
belong to the Inflammation cluster, while those in M2 belong to
Positive Differentiation, and several genes related to both M1 and M2
polarization belong to Inflammation Driven Differentiation. That this
reported. Statistical significance was calculated with ANOVA followed by Fisher’s test for significant differences between two consecutive
experimental time points. * P,.05; ** P,.001; *** P,.0001.
doi:10.1371/journal.pone.0087680.g004
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latter cluster is related to both activation programs suggests that
inflammation is a process strictly connected to macrophage
differentiation. Thus, that the genes involved in inflammatory
activation belong to the same biological pathways involved in
cellular processes of monocyte-to-macrophage differentiation
establishes a transcriptional connection between monocyte acti-
vation and differentiation, inflammation and metabolism. There-
fore, resolution of inflammation is strictly connected to macro-
phage differentiation in the tissue.
These observations suggest that monocytes entering an inflam-
matory environment first polarise into M1, and then switch to M2
upon microenvironmental changes. The fact that the same
monocyte population goes through all the phases of the
inflammatory process by adapting its phenotype and function to
the evolution of microenvironmental conditions was already
suggested by studies in mouse models [11–13], but never
previously shown for human cells.
The shift from M1 to M2 was confirmed by assessing
quantitative gene expression and protein production for a series
of cytokines, markers and transcriptional factors involved in both
monocyte differentation and macrophage polarization. Our data
confirmed that expression of MAFB, a myeloid differentiation
marker, correlates with expression of its target genes CD163 and
MMP9 [45], which increase during the resolution phase.
Expression of PPARG and PPARD increased during the inflam-
mation phases (PPARD maintaining high expression also during
resolution), confirming their role in inflammation [46], and in
control of monocyte-to-macrophage differentiation [47], respec-
tively. KLF4 and CEBPA, critical regulators of monocyte differen-
tiation, showed an opposite expression profile, the former being
significantly downregulated throughout, while the latter was
strongly upregulated during late resolution. The observed PPARG
and KLF4 expression profiles do not agree with the reported
observation that these factors are linked to M2 polarization [48].
However, previous studies addressed M2a polarization (type II
inflammation), at variance with our model exclusively focused on
M2c polarization (deactivation), which is functionally very
different. Thus, while transcriptional factors may variously
contribute to macrophage polarization, downregulation of PPARG
and KLF4 in parallel to upregulation of MAFB seem to be critical
for monocyte to M2c differentiation.
Overall, this study shows that an in vitro system based on
primary human cells can allow us to describe the kinetic
development of cell reactivity and its modulation during the
entire course of the inflammatory response in a robust and reliable
fashion. The use of such human primary cell-based models are
bound to provide information readily transferrable to human
reactivity in vivo, and to identify regulatory pathways associated
with physiological response or with persistent and pathological
inflammation.
Supporting Information
Figure S1 Data visualization by cluster analysis. Nine
separated clusters are shown. Solid red lines have been drawn
joining the average value of gene expression at each time point for
each donor (dots). In the text the clusters are reported as follows: 1
and 2 as Inflammation (218 and 174 genes, respectively), 3 as Early
Anti-Inflammation (850 genes), 4 and 5 as Anti-Inflammation (445 and
576 genes respectively), 6 as Inflammation Driven Differentiation (457
Figure 5. Rate of cytokine and chemokine production in the
course of in vitro inflammation. Production of inflammatory
chemokines CXCL8 (IL-8) and CCL5 (RANTES), and of the cytokine IL-6
during the in vitro inflammatory reaction. Production of soluble proteins
released in the supernatant is reported in terms of rate of production,
i.e., the amount of protein produced per one million cells per hour. The
mean values 6 SEM of three different donors are reported. Statistical
significance was calculated with ANOVA followed by Fisher’s test for
significant differences between two consecutive experimental time-
points. * P,.05; ** P,.001; *** P,.0001.
doi:10.1371/journal.pone.0087680.g005
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genes), 7 as Positive Differentiation (214 genes), 8 and 9 as Negative
Differentiation (680 and 381 genes, respectively).
(TIFF)
Table S1 Complete list of the datasets used in this study
and their sources. Genome-wide expression levels and meta-
information of 303 samples were organized in a proprietary
database using A-MADMAN.
(DOCX)
Table S2 Complete list of 128 samples labeled as
untreated monocytes and as M1 and M2 activated
monocytes and their sources.
(DOCX)
Table S3 Complete list of genes differentially expressed
during the course of the in vitro inflammatory reaction.
NA: not attributed
(XLS)
Table S4 Complete list of the genes differentially
expressed between untreated monocytes and M1 mac-
rophages, extracted from database.
(DOCX)
Table S5 Complete list of the genes differentially
expressed between untreated monocytes and M2 mac-
rophages, extracted from database.
(DOCX)
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